-
Something wrong with this record ?
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review
V. Paudyal, B. Okuyan, MC. Henman, D. Stewart, D. Fialová, A. Hazen, M. Lutters, A. Oleárová, AE. Weidmann, F. Wirth, CA. Cadogan, Z. Nazar
Language English Country Netherlands
Document type Systematic Review, Journal Article, Review
NLK
ProQuest Central
from 2011-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-02-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2011-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 2011-02-01 to 1 year ago
- MeSH
- Pharmacy * MeSH
- Communication * MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Systematic Review MeSH
- Geographicals
- Australia MeSH
- Ireland MeSH
BACKGROUND: Guidelines for pharmacy practitioners regarding various clinical pharmacy activities have been published in a number of countries. There is a need to review the guidelines and identify the scope of activities covered as a prelude to developing internationally acceptable common guidelines. AIM: To review the scope of clinical pharmacy guidelines and assess the extent to which these guidelines conform to quality standards as per the AGREE II instrument. METHOD: Medline, Embase, Guideline Central, International Pharmaceutical Abstracts, Google Scholar and Google (for grey literature) were searched for the period 2010 to January 2023. Guidelines which focused on any health care setting and any clinical pharmacy activity were included. Data were extracted and quality assessed independently by two reviewers using the English version of the AGREE II instrument. RESULTS: Thirty-eight guidelines were included, mostly originating from Australia (n = 10), Ireland (n = 8), UK (n = 7) and USA (n = 5). Areas covered included medication reconciliation, medicines optimisation, medication management and transition of care. As per the AGREE II assessment, the highest score was obtained for the scope and purpose domain and the lowest score for rigour of development, mainly due to non-consideration of literature/evidence to inform guideline development. CONCLUSION: Clinical pharmacy guidelines development processes need to focus on all quality domains and should take a systematic approach to guideline development. Guidelines need to further emphasise person-centred care and clinical communication. There is a scope to harmonise the guidelines internationally considering the diverse practices, standards and legislations across different geographies.
College of Pharmacy QU Health Qatar University Doha Qatar
Department of Clinical Pharmacology Bratislava University Hospital Bratislava Slovakia
Department of Clinical Pharmacy Faculty of Pharmacy Marmara University Istanbul Türkiye
Department of Clinical Pharmacy Innsbruck University Innsbruck Austria
Department of Pharmacy University of Malta Msida Malta
Kantonsspital Aarau Aarau Switzerland
School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007398
- 003
- CZ-PrNML
- 005
- 20240423155925.0
- 007
- ta
- 008
- 240412s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11096-023-01658-x $2 doi
- 035 __
- $a (PubMed)37991663
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Paudyal, Vibhu $u School of Pharmacy, College of Medical and Dental Sciences, Sir Robert Aitken Institute for Medical Research, University of Birmingham, Edgbaston, Birmingham, UK. v.paudyal@bham.ac.uk $1 https://orcid.org/0000000241736490
- 245 10
- $a Scope, content and quality of clinical pharmacy practice guidelines: a systematic review / $c V. Paudyal, B. Okuyan, MC. Henman, D. Stewart, D. Fialová, A. Hazen, M. Lutters, A. Oleárová, AE. Weidmann, F. Wirth, CA. Cadogan, Z. Nazar
- 520 9_
- $a BACKGROUND: Guidelines for pharmacy practitioners regarding various clinical pharmacy activities have been published in a number of countries. There is a need to review the guidelines and identify the scope of activities covered as a prelude to developing internationally acceptable common guidelines. AIM: To review the scope of clinical pharmacy guidelines and assess the extent to which these guidelines conform to quality standards as per the AGREE II instrument. METHOD: Medline, Embase, Guideline Central, International Pharmaceutical Abstracts, Google Scholar and Google (for grey literature) were searched for the period 2010 to January 2023. Guidelines which focused on any health care setting and any clinical pharmacy activity were included. Data were extracted and quality assessed independently by two reviewers using the English version of the AGREE II instrument. RESULTS: Thirty-eight guidelines were included, mostly originating from Australia (n = 10), Ireland (n = 8), UK (n = 7) and USA (n = 5). Areas covered included medication reconciliation, medicines optimisation, medication management and transition of care. As per the AGREE II assessment, the highest score was obtained for the scope and purpose domain and the lowest score for rigour of development, mainly due to non-consideration of literature/evidence to inform guideline development. CONCLUSION: Clinical pharmacy guidelines development processes need to focus on all quality domains and should take a systematic approach to guideline development. Guidelines need to further emphasise person-centred care and clinical communication. There is a scope to harmonise the guidelines internationally considering the diverse practices, standards and legislations across different geographies.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a komunikace $7 D003142
- 650 12
- $a farmacie $7 D010604
- 651 _2
- $a Irsko $7 D007494
- 651 _2
- $a Austrálie $7 D001315
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Okuyan, Betul $u Department of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Türkiye $1 https://orcid.org/0000000240232565
- 700 1_
- $a Henman, Martin Charles $u Trinity College Dublin, Dublin, Ireland
- 700 1_
- $a Stewart, Derek $u College of Pharmacy, QU Health, Qatar University, Doha, Qatar $1 https://orcid.org/0000000173608592
- 700 1_
- $a Fialová, Daniela $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Hazen, Ankie $u Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
- 700 1_
- $a Lutters, Monika $u Kantonsspital Aarau, Aarau, Switzerland
- 700 1_
- $a Oleárová, Anna $u Department of Clinical Pharmacology, Bratislava University Hospital, Bratislava, Slovakia
- 700 1_
- $a Weidmann, Anita E $u Department of Clinical Pharmacy, Innsbruck University, Innsbruck, Austria
- 700 1_
- $a Wirth, Francesca $u Department of Pharmacy, University of Malta, Msida, Malta
- 700 1_
- $a Cadogan, Cathal A $u School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
- 700 1_
- $a Nazar, Zachariah $u College of Pharmacy, QU Health, Qatar University, Doha, Qatar $1 https://orcid.org/0000000341044221
- 773 0_
- $w MED00180241 $t International journal of clinical pharmacy $x 2210-7711 $g Roč. 46, č. 1 (2024), s. 56-69
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37991663 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155922 $b ABA008
- 999 __
- $a ok $b bmc $g 2081397 $s 1217165
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 46 $c 1 $d 56-69 $e 20231122 $i 2210-7711 $m International journal of clinical pharmacy $n Int J Clin Pharm $x MED00180241
- LZP __
- $a Pubmed-20240412